Dataset from A Phase 1, Open Label, Randomized, Parallel Group Study to Assess the Absolute Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007362
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the absolute bioavailability and pharmacokinetics of
vedolizumab following a single injection of vedolizumab subcutaneously at 3 varying doses.
创建时间：
2025-10-01
